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A deterministic oscillatory model of microtubule
growth and shrinkage for diﬀerential actions of
short chain fatty acids†
Josephine Kilner,a Bernard M. Corfe,*bc Mark T. McAuleyd and
Stephen J. Wilkinsonad
Short chain fatty acids (SCFA), principally acetate, propionate, butyrate and valerate, are produced in
pharmacologically relevant concentrations by the gut microbiome. Investigations indicate that they exert
beneficial eﬀects on colon epithelia. There is increasing interest in whether diﬀerent SCFAs have distinct
functions which may be exploited for prevention or treatment of colonic diseases including colorectal
cancer (CRC), inflammatory bowel disease and obesity. Based on experimental evidence, we hypothe-
sised that odd-chain SCFAs may possess anti-mitotic capabilities in colon cancer cells by disrupting
microtubule (MT) structural integrity via dysregulation of b-tubulin isotypes. MT dynamic instability is an
essential characteristic of MT cellular activity. We report a minimal deterministic model that takes a
novel approach to explore the hypothesised pathway by triggering spontaneous oscillations to represent
MT dynamic behaviour. The dynamicity parameters in silico were compared to those reported in vitro.
Simulations of untreated and butyrate (even-chain length) treated cells reflected MT behaviour in
interphase or untreated control cells. The propionate and valerate (odd-chain length) simulations displayed
increased catastrophe frequencies and longer periods of MT-fibre shrinkage. Their enhanced dynamicity was
dissimilar to that observed in mitotic cells, but parallel to that induced by MT-destabilisation treatments.
Antimicrotubule drugs act through upward or downward modulation of MT dynamic instability. Our
computational modelling suggests that metabolic engineering of the microbiome may facilitate
managing CRC risk by predicting outcomes of SCFA treatments in combination with AMDs.
1. Introduction
Colorectal cancer (CRC) is the fourth most common cancer and
second leading cause of cancer-related death in the UK.1 Short
chain fatty acids (SCFA) are closely associated with colon
epithelia as by-products of anabolic fermentation by gut
bacteria.2 The principle SCFAs in the human gut are acetate,
propionate, butyrate and valerate. These diﬀer in carbon chain
lengths (2, 3, 4 & 5 carbons, respectively). Butyrate is the most
researched to date for colon health. It is the preferred energy
source for the colonocyte, a potent regulator of cell fate,3
particularly apoptosis,4,5 and is thought to be chemopreventive.
SCFAs have been shown to induce acetylation of target proteins,
either via histone deacetylation6,7 or by shifting the balance
of acetyl-CoA reactions towards acetylation;6,7 however, the mecha-
nistic details of their functions in colonocytes are unclear. Our
previous empirical work and others6,8 suggested that carbon chain
length may impact on their actions, with odd and even carbon-
length SCFAs possessing distinct functions by virtue of diﬀerent
pathways in b-oxidation and entry into the TCA cycle.
Microtubules (MT) are cytoskeletal proteins that perform
many critical cellular functions. In addition to maintaining cell
structure, motility, intra- and intercellular transport, they are
central to accurate formation and control of the mitotic spindle
during cell division. MT fibres are composed of typically 13
protofilaments arranged longitudinally, each of which is con-
structed from ab-tubulin heterodimers arranged in a head-to-
tail manner. This confers the MT fibre with polarity so that
polymerisation primarily occurs at the plus end. During assembly,
the a-tubulin subunits are bound within the fibre and inaccessible
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to external proteins; conversely, the b-tubulin subunits are exposed
on the surface enabling them to undergo post-translational modi-
fications (PTM) and interact with microtubule associated proteins
(MAP), including dynein and kinesin motor proteins. The arrange-
ment of b-tubulin isotypes along the fibre combined with their
PTMs has been hypothesised to generate a tubulin code that
may direct MT functions and regulate MT behaviour.9,10 In order
to perform their molecular functions MTs require the ability to
rapidly grow, shrink and change direction in response to cellular
cues. These transitions are an essential characteristic of MTs and
are termed dynamic instability. The accepted view of MT dynamic
instability is the MT capping model.11 Briefly, phosphorylated
ab-tubulin dimers bind to the plus end of the MT fibre to form
a protective tubulin–GTP cap. Immediately following poly-
merisation, the b-tubulin–GTP subunits undergo irreversible
hydrolysis to their GDP form. Although this provides the
necessary energy to drive MT growth,12 b-tubulin–GDP is
unstable and the fibre will rapidly dissociate if the protective
GTP cap is not sustained. This is termed catastrophe and
occurs when the pool of ab-tubulin–GTP subunits in the
vicinity of the fibre tip falls below a critical concentration.13
Once released into the cytosol, b-tubulin–GDP subunits are free
to rephosphorylate, restoring the critical concentration and
enabling MT growth to resume, termed rescue. These actions
are illustrated in Fig. 1A. Experimental evidence on MT
dynamics has primarily been derived from fluorescent tracking
microscopy of growing and shrinking MTs in vitro.14–18 The life
history of an MT within a cell can range from several minutes to
hours and involves extended periods of slow growth, short
periods of rapid shrinkage and time spent pausing. Each period
of elongation and shortening can consist of multiple catastrophes
and rescues (Fig. 1B).17,18 Despite appearing random, MT dynamic
instability is a tightly regulated and orchestrated process.
Polymerisation of a b-tubulin GTP subunit to an MT fibre
and its subsequent hydrolysis is a cooperative procedure.
Suggested mechanisms include chemical and protein–protein
interactions between b-tubulin GTP and GDP subunits;19 con-
formational changes arising from GTP hydrolysis;20 and facilitated
diffusion. The latter mechanism postulated that ab-tubulin dimers
are transported towards the plus end of an MT fibre by virtue of
fibre’s polarity; as such, the probability that a dimer encounters an
MT will increase as the MT lengthens.21
The b-tubulin superfamily comprises of six principle classes
thought to have functional significance.22,23 Most b-tubulin
isotypes are species, tissue or cell type specific. Their relative
proportions within an MT fibre can be regulated by upstream
signalling events, suggesting they may influence MT functional
activity.24 Consequently, disrupting the fine balance of b-tubulin
isotypes can lead to aberrant tubulin behaviour and may have
implications in the progression of colonic diseases, including
CRC.18,24
Our proteomic analyses investigated proteins diﬀerentially
regulated in colon cancer cells by treatment with butyrate,
propionate and valerate. The results identified several cyto-
skeletal proteins that were significantly dysregulated:25 all three
SCFAs targeted keratin 19; butyrate and propionate targeted
actin; and propionate primarily targeted keratins 8 and 18;
however, only propionate and valerate significantly targeted
b-tubulin isotypes b2c-, b3- and b1-tubulin. These findings were
consistent with our high content analyses (HCA) that had
revealed valerate and propionate were the most eﬀective in
inducing MT breakdown and G2/M cell cycle arrest, despite
being weaker eﬀectors in apoptotic functions.5,26 Whereas
butyrate induces cytoskeletal breakdown via apoptosis,4,5 these
observations suggested that propionate and valerate may act
through diﬀerent mechanisms. Based on this evidence, it was
hypothesised that odd- and even-chain SCFAs possessed distinct
and unique metabolic functions.
SCFAs act by promoting post-translational acetylation
of target proteins. Bioinformatic searches of Reactome and
SABiosciences24,27,28 indicated that the activities of several
transcriptional regulators (TR) associated with b2c-, b3- and
b1-tubulin genes (RFX, PPAR, NSFR and NF-kB) could be altered
by acetylation. Histone acetylation also induces chromatin
remodelling to promote transcription of target genes and can
itself be influenced by upstream acetylation events.29,30 These
results suggested that treatment of colonocytes with SCFAs
altered the regulation of specific genes, including overexpression
of b2c- and b3-tubulin and suppression of b1-tubulin transcrip-
tion via acetylation of NF-kB.31,32 Both b2c- and b3-tubulin have
been implicated in MT destabilisation;24 although less is known
about the role of b1-tubulin in MT dynamics.
Computational modelling has contributed to a better under-
standing of MT functions20,33–36 and the biophysical details of
MT dynamic instability. Various approaches have been adopted,
including Monte Carlo simulations;20,33 simplified coarse-grained
stochastic models;35 one- and three-dimensional modelling;37 and
models focusing on different types of lattices and MT fibre–fibre
interactions.33,36 The term ‘‘structural plasticity’’ invokes mechan-
isms more dependent on the structural conformations of bound
subunits than their chemical states.19 Simulated systems of
dynamic MTs have also advanced understanding of their associa-
tions with MAPs, the collective behaviour of MTs and motors, and
have been used to replicate mitotic events.38,39 The model of
Bayley et al. (1990) was pivotal in demonstrating the validity of the
Fig. 1 Qualitative, stochastic and deterministic representations of MT
dynamic instability. (A) (left) A growing MT fibre showing the protective
cap (dark circles) formed from ab-tubulin dimers with b-tubulin–GTP
subunits; (right) an MT fibre undergoing catastrophe showing rapidly
dissociating dimers with hydrolysed b-tubulin–GTP subunits (white circles).
(B) The stochastic nature of MT dynamic instability in vivo and in vitro
showing the life history of a growing MT as a series of catastrophe and
rescue events. (C) A deterministic representation of MT dynamic instability
in silico showing regular periodic cycles in MT growth and shrinkage without
the need for random perturbations.
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lateral-capmodel, in which b-tubulin–GTP assembly is a cooperative
stochastic event that is fully coupled with b-tubulin hydrolysis.40
Their hypothesis was supported by Pedigo andWilliams (2002) who
showed that conformational changes arising from b-tubulin–GTP
hydrolysis directly after association was best described using kinetic
principles of lattice interactions.20 Computationalmodels have been
proposed as a basis for predicting the actions of antimicrotubule
drugs (AMDs).40,41 This had particular relevance for our investi-
gation which aimed to explore the links between SCFAs, tran-
scriptional regulation of b-tubulin isotypes, MT integrity and
performance, and the potential use of SCFAs in adjuvant therapies
in CRC.
A common approach to modelling systems of this nature is
to use ordinary diﬀerential equations (ODEs). These present
biological systems as continuous and deterministic and assume
that randomness is not an important factor in the system of
interest. An alternative approach is to use stochastic models if
there is deemed to be inherent variability within the biological
system; a stochastic approach will be used in scenarios whereby
a small number of molecules are suggested to be involved in
discrete random collisions, such as during the expression of a
single gene. The main limitation of stochastic models is that
they have a tendency to be computationally intensive, as
reviewed in McAuley et al. (2013).42 In this study, we sought to
develop a minimal deterministic model based on experimental
evidence that might explain or validate our hypothesis:25 that
diﬀerent SCFAs imposed diﬀerential eﬀects on the balance of
b-tubulin isotypes and their impact on MT integrity. A comparison
between the stochastic behaviour of MTs in vivo and in vitro and a
deterministic representation in silico is presented in Fig. 1B and C.
2. Methods, kinetic theory
and simulations
2.1 Qualitative model and design
The rationale underpinning the selection of a deterministic model
made up of ODEs was based on our experimental observations.
These had demonstrated that this system was deterministic and
the inherent variability was negligible. The schematic diagram
in Fig. 2 shows the key events in the hypothesised pathway.
Two scenarios are presented: the first represents untreated cells
displaying normal MT behaviour (Fig. 2A); the second represents
SCFA-treated cells promoting perturbation of MT dynamic
instability (Fig. 2B). The first three reactions (k1–k3) are involved
in the synthesis of the differentially regulated b-tubulin isotypes
(b2c-, b3- and b1-tubulin); the next three reactions (k4–k6) are
involved in MT dynamic instability based on the capping model.11
With the exception of the perturbation step, the two parts of the
model are distinct; therefore, no feedback loop has been included
between the synthesis of beta in the first part and the concen-
tration of free b-tubulin subunits (tuGTP) in the second part. This
was based on the assumption that the total number of b-tubulin
subunits (free and bound) in the system is fixed but the relative
proportions of stabilising and destabilising isotypes can shift.
Consequently, the net upregulation of the three targeted b-tubulin
isotypes (beta) will be compensated by a net downregulation
distributed among the remaining b-tubulin isotypes. (Based on
our experimental results, none of the other b-tubulin isotypes was
individually significantly downregulated.)
The pathway in Fig. 2B (treatment with odd-chain SCFAs) is
described below:
 [k1–k3]: Treatment with odd-chain SCFAs drives acetyla-
tion of the target transcriptional regulators (TR); the acetylated
TRs induce histone acetylation at b2c-, b3- and b1-tubulin
genes (denoted beta); thereby enhancing or extending synthesis
of these b-tubulin isotypes.
 [k4–k6]: Free phosphorylated b-tubulin–GTP subunits
co-operatively bind to the plus end of the MT fibre and are rapidly
hydrolysed to their unstable b-tubulin–GDP form; dissociation of
the MT fibre (catastrophe) releases the bound b-tubulin–GDP
subunits back into the cytosol where they are re-phosphorylated,
enabling MT re-polymerisation (rescue) to resume.
Fig. 2 Schematic diagram representing the hypothesised eﬀects of SCFA
treatments on microtubule dynamic instability in colon cancer cells.
(A) Butyrate (an even-chain SCFA) has little or no impact on the regulatory
pathway (k1-k3) leading to normal synthesis of the three target b-tubulin
isotypes (beta) relative to untreated cells. Therefore MT dynamic instability
(k4-k6) remains unperturbed. (B) In contrast, treatment with propionate
or valerate (odd-chain SCFAs) induces dysregulation of beta leading to
perturbation of MT dynamicity by promoting depolymerisation of the MT
fibre (k6). Arrows show forward and backward reactions; round-ended
arrows indicate the target reaction is promoted by the product of the
preceding reaction; changes in the concentrations of reactants are repre-
sented by changes in the diameters of the circles. The following abbreviations
are adopted: TR, transcriptional regulators; HST, histones at the target genes;
beta, the combined weighted fold-change of b3-, b2c- and b1- tubulin
isotypes; MT, the MT fibre; tuGTP and tuGDP, total free phosphorylated
and hydrolysed b-tubulin subunits, respectively; ac refers to the acetylated
forms of TR and HST; p indicates phosphorylation; SCFAcoeﬀ, the SCFA-
activation coeﬃcient specific to the hypothesised pathway.
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 The cycle then repeats.
The eﬀect of raising the proportion of these three MT-
destabilising b-tubulin isotypes in the system was to drive
depolymerisation of the MT fibre, thereby inducing catastrophe.
In contrast, untreated simulations or treatment with even-chain
SCFAs (Fig. 2A) had little impact on the acetylation of target TRs,
thereby preserving MT dynamic instability.
The modelled reactions obeyed kinetic rules and the relation-
ships between the reactants were based on published observables
and experimental data. Within the specifications of the modelled
system, and due to the complexities of biological processes, each
reaction in the pathway represented a number of intermediate
sub-reactions. This approach of model reduction meant that the
kinetic variables of the combined reactions could not be defined.43
Reaction rates can also be altered by post-translational modifica-
tions.44 As a result, parameters were set within biologically feasible
limits derived from similar reactions reported in curated bio-
models.45 However, computational strategies have demonstrated
that modelling can be successful in gaining valuable insights into
biological mechanisms even under conditions where kinetic or
reactant data are limited or unknown.46,47
2.2 Initial concentrations of reactants
The initial reactant concentrations are summarised in the ESI†
(Table S1). Our proteomic data was used to define the steady
state concentrations of beta relative to untreated values, (1.07,
1.34 and 1.40 for butyrate, propionate and valerate, respectively).
To match these values, the corresponding SCFA activation
coeﬃcients (SCFAcoeﬀ) were manually adjusted to 1.2, 2.8, and
3.6, respectively. This is an accepted approach that has been
described previously.39 The total concentration of tubulin in the
system was set at 10.0 mM based on typical values reported in
the literature.11,14,18,48 Although the concentrations of MTs, and
bound and free b-tubulin subunits continually fluctuated, the
overall concentration was assumed to be constant within the
fixed volume of the in silico cell. Therefore, the initial concentra-
tions could be arbitrarily set as MT = 5.5 mM; tuGDP = 3 mM;
tuGTP 1.5 mM. These were informed estimates based on the
nature of MT dynamic instability. Sensitivity analyses were
performed to verify that the estimated values and assumptions
were reasonable and appropriate, and to identify those parameters
that would have the greatest impact of the model outcomes.
2.3 Kinetic rate laws and ODEs
The rate law interpretation was set as deterministic. The kinetic
reactions, rate constants, rate laws and ODEs are summarised
in the ESI† (Tables S2 and S3). The three steps of MT dynamic
instability (b-tubulin phosphorylation, rescue and catastrophe;
Fig. 2B) were inspired by Tyson’s two-species model of cell
division that displays spontaneous oscillations within set con-
straints.49 This in turn had been based on the hypothetical
model of a mitotic oscillator50 and theoretical Brusselator
model of chemical oscillations.51,52 In this study we used a
similar approach to construct a minimal oscillating model to
describe MT dynamics in which the key requirement was for
cooperative/non-linear kinetics within the cycle. By reducing
MT dynamic instability to its three fundamental steps required
us to ignore many of the additional levels of complexity, such as
protein structure and memory eﬀects.53 Neglecting stochastic
eﬀects was also a major simplification even though the apparent
randomness of dynamic instability is likely to be an important
driving force in the true picture. However, the aim of this work
was to show that cooperative kinetics for MT growth, dependant
on a minimal concentration of free b-tubulin–GTP subunits, and
a first order dissociation, could give credible results.
2.4 Simulations and output parameters
The key parameters of MT dynamicity are growth and shrinkage
periods and rates and catastrophe and rescue frequencies;
catastrophe frequency is defined as the number of transitions
from growth to shrinkage relative to the total elongation time;
rescue frequency is defined as the number of transitions from
shrinkage to growth relative to the total shrinkage time.14,17
The time MTs spend pausing was beyond the scope of this
model and not included in the analyses. As described earlier, an
MT can undergo multiple sub-events of growth and shrinkage,
catastrophes and rescues during its life history. These have been
depicted as micro-oscillations.
The ratios of catastrophe:rescue frequencies, growth:shrinkage
rates and growth:shrinkage times were calculated from the tem-
poral data in order for equivalent comparisons to be made against
the wide range of experimental data.
The simulations were undertaken in COPASI v4.7.54 The
simulation times ranged from 0 to 600–1000 s and data were
recorded at intervals of 0.5 s. This provided a sufficient number
of oscillations at a sensitivity suitable for analysis. The MT
dynamicity parameters were evaluated following an initial delay
of 500 s to allow b-tubulin synthesis to reach steady state
(Fig. 3A).
3. Results
3.1 MT dynamicity parameters for SCFA treatments in silico
The inter-relationships between MT fibres and b-tubulin GTP
and GDP subunits (MT, tuGTP and tuGDP, respectively;
Fig. 3B): MT polymerisation commenced when the concen-
tration of free tuGTP reached a critical concentration (cc); MT
dissociation was triggered when the concentration of tuGTP fell
below the cc; the subsequent decrease in MT concentration
(representing length) was reflected by an increase in the
concentration of free tuGDP. This model was based on the
assumption that the concentration of free b-tubulin (tuGTP and
tuGDP) was not constant but fluctuated in response to MT fibre
growth and shrinkage. This implies that the concentration of
free b-tubulin–GTP may play a role in MT dynamic instability.
Although this supposition is relatively novel, it is not unprece-
dented: Janulevicius et al. (2006) explored this hypothesis
through Monte Carlo simulations in the context of small
cellular compartments and fluctuations in the concentration
of free tubulin, and by extension, situations that affect the
probability of MT association.55 Their model was equated to
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neuronal growth cones in vivo; our model was based on changes
in the local concentration of free b-tubulin–GTP at the fibre
tip due to facilitated diffusion,21 and thereby the probability of
association.
The temporal simulations for MTs for each SCFA treatment
are shown in Fig. 4A. The mean periods of the micro-oscillations
were approximately 20 s. This was consistent with published values
in vitro and in vivo for fluorescently tagged MTs.17,18,56 Qualitative
examination of the profiles showed that there was little diﬀerence
between MT dynamicity in untreated cells in silico and those
treated with butyrate (Fig. 4A). In both cases, the cycle of dynamic
instability persisted over the simulation time and the mean
concentration of MTs was 94% for butyrate relative to untreated
values. In contrast, the MT profiles for propionate and valerate
treatments showed increasing dampening of the oscillations,
reflecting suppression of MT dynamic instability, and a reduction
in the mean concentrations of MTs to 74% and 71% relative to
untreated values, respectively. Fig. 4B shows the corresponding
rate-profiles in untreated cells and valerate treated cells. These
include the rates of concentration changes for MTs and free GTP
and GDP b-tubulin subunits. Together, these results demonstrated
that odd- and even-chain SCFAs induced distinct actions on MT
dynamic instability. The odd-chain SCFAs eﬀectively abolished MT
dynamic instability in silico, reflecting dissociation of the fibres
and loss of MT integrity in vitro, consistent with our experimental
iTRAQ and HCA observations in HCT116 colon cancer cells.
Comparisons between the simulated MT-dynamicity values for
the three SCFAs relative to untreated values (Table 1) showed that
the catastrophe frequencies were increased, the rescue frequen-
cies decreased, the growth:shrinkage times increased and the
growth:shrinkage rates decreased in the order butyrate to pro-
pionate to valerate, with valerate having the greatest eﬀect.
3.2 Comparisons between MT dynamicity parameters in silico
and experimental data in vitro
In order to determine whether the modelled outcomes could
plausibly be attributed to MT destabilising treatments in vitro,
they were compared to experimental measurements of MT
dynamicity parameters in cells at diﬀerent phases or under-
going diﬀerent treatments. Experimental observations can yield
a wide range of values for MT dynamicity dependent on species,
tissue or cell type and external conditions; however they tend to
report similar trends and ratios. For this reason, data from two
representative reports were selected for interphase and mitotic
epithelial cells,17 and MT-destabilising and MT-stabilising
treatments in epithelial cells18 to minimise compounding eﬀects.
The experimental values are summarised in the ESI† (Table S4).
The histograms in Fig. 5 indicate that MT dynamicity ratios in
untreated and butyrate treated cells in silicomost closely matched
those in interphase cells in vitro for growth and shrinkage but
were closer to stabilised-control cells for catastrophe and rescue
Fig. 3 Temporal simulations showing the relationships between micro-
tubule fibres and subunits in the hypothesised pathway. (A) Treatment with
propionate and valerate (odd-chain SCFAs) significantly promotes synthesis of
target b-tubulin isotypes (beta: b2c-tubulin, b3-tubulin, b1-tubulin); whereas
butyrate has little influence on beta synthesis relative to untreated cells. The
curves show the relative concentrations of beta following treatment with
valerate (upper), propionate (centre) and butyrate (bottom). Steady state is
achieved at approximately 500 s; the simulation time is 1000 s. (B) The stacked
curves show the inter-relationships between MT fibres (MT, middle) free
b-tubulin GTP and GDP subunits (tuGTP and tuGDP, top and bottom,
respectively): the rapid gain and slow decline in free tuGDP is reflected by a
rapid loss and slow increase in free tuGTP and consequently rapid shrinkage
(catastrophe) and slow growth (rescue) in MT fibres; (a) indicates the point of
rescue; (b) and (c) denote the critical concentration of tuGTP at which the
protective cap at the end of the MT fibre is established and lost, respectively.
Simulation time, 500–530 s.
Fig. 4 Temporal simulations showing MT dynamic behaviour under diﬀerent
SCFA treatments. (A) Micro-oscillations depicting catastrophe and rescue
events in simulated SCFA treatments during 60 s of the MT’s lifespan: (left
to right) untreated; butyrate (even-chain, 4 carbons); propionate (odd-chain,
3 carbons); and valerate (odd-chain, 5 carbons). There is little change in MT
dynamicity between untreated and butyrate treated cells and MT dynamic
instability persists over time; however, treatments with propionate and valerate
reduce growth periods, increase shrinkage periods and suppress MT dynamic
instability. (B) The rates of changes in MTs and free GDP and GTP b-tubulin
(tuGDP and tuGTP) concentrations for untreated and valerate treated simula-
tions show the predominance of second-order cooperative association in
untreated MTs (left) and the shift towards first-order dissociation in valerate
treated MTs (right).
Table 1 Fold-changes in the MT-dynamicity parameters for simulated
treatments with SCFAs relative to untreated values in silico
MT dynamicity parameter Butyrate Propionate Valerate
Catastrophe frequency [s1] 0.98 1.08 1.24
Rescue frequency [s1] 0.97 0.83 0.72
Catastrophe:rescue frequency 1.01 1.29 1.73
Relative time growing 1.00 0.94 0.80
Relative time shrinking 1.01 1.21 1.39
Growth:shrinkage times 0.99 0.77 0.58
Growth rate [mM min1] 0.92 0.13 0.001
Shrinkage rate [mM min1] 0.91 0.10 0.000
Growth:shrinkage rates 1.01 1.29 1.45
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frequencies (Fig. 5A). Whereas, propionate and valerate treated
MTs in silico displayed similarities to both mitotic and destabi-
lised MTs in vitro for growth and shrinkage times and rates, but
only to MT-destabilising treatments for catastrophe and rescue
frequencies (Fig. 5B). Both mitotic and depolymerising MTs are
dynamically active; however, these simulations strongly suggested
that colon cancer cells treated with odd-chain SCFAs undergo
MT-destabilisation as opposed to enhanced mitosis. These results
supported our proposition that odd-chain SCFAs at above physio-
logical concentrations may act as anti-microtubule agents.
3.3 Sensitivity analyses: influences of initial concentrations
and kinetic rate constants on model behaviour
Sensitivity analyses were carried out using the generic sensitivity
framework in COPASI to assess the impacts of the initial reactant
concentrations and kinetic rate constants on the reaction fluxes
and temporal concentrations of the reactants, respectively. The
summarised and scaled results are given in the ESI† (Table S5)
and shown graphically in Fig. 6A. The parameters with the greatest
influences upstream of MT dynamic instability (k1-k3) were the
initial concentration of histones (HST) and the forward kinetic rate
constant for synthesis (k3f) of beta (the three targeted b-tubulin
isotypes): a 10% increase in the initial concentration of HST
resulted in complete loss of MT dynamicity (Fig. 6B, centre);
whereas a 10% increase in the forward rate of beta synthesis led
to over-stabilisation of the MTs (Fig. 6B, right), eﬀectively negating
the destabilising eﬀects of valerate treatment (Fig. 6B, left).
The dynamicity control factor that had the greatest influence
in the cycle of MT dynamic instability was the rate of rephos-
phorylation of free tuGDP subunits (k6) (Fig. 6A).
4. Discussion
Antimicrotubule drugs have proved highly successful in the
treatment of multiple cancers and other diseases, such as
motor neuron disease.57,58 The review by Jordan and Wilson
(2004) describes the ability of AMDs to induce apoptosis via
mitotic arrest by suppressing MT dynamic instability.59 It was
also suggested that cancer cells may dysregulate expression of
b-tubulin isotypes in order to enhance resistance to AMDs.60 To
date, SCFAs have not been directly identified as antimitotic
agents, and experimental investigations have primarily focused
on their ability to induce cell death and subsequent cytoskeletal
breakdown viamechanisms that include alterations in pro- and
anti-apoptotic proteins and tumour suppressor genes through
Sp1 and Bcl-2 family proteins.26,61 The importance of MAPs as
the driving forces in dynamic instability is becoming increas-
ingly evident.55 This implies that the diﬀerent b-tubulin iso-
types also play critical roles through recruitment of MAPs. We
previously reported that propionate and valerate, both odd-
chain SCFAs, dysregulated the balance of b-tubulin isotypes
Fig. 5 Goodness of fit of model to empirical data. Comparisons between
model predictions and published observations of MTs in vitro show that (A)
simulations for untreated and butyrate (even-chain SCFA) treated MTs in
silico most closely reflect those in interphase cells (I) for growth:shrinkage
[g:s] periods and rates in vitro, and control cells in stabilising experiments
(C-s) for catastrophe:rescue [cat:res] frequencies; (B) propionate and
valerate (odd-chain SCFAs) treated MTs in silico most closely reflect MTs
undergoing destabilising treatments (Ds) in vitro for all three MT dynamicity
ratios; although they bear close similarities to mitotic cells (M) for
growth:shrinkage periods and rates, they exhibit highly diﬀerent behaviour
from mitotic cells undergoing catastrophe and rescue. Note, the bars for
growth:shrinkage times for Cd and St extend beyond the scale of the charts.
[U, B, P, V: untreated, butyrate, propionate and valerate treatments in silico,
respectively; I, M, Cs, Cd, St, Ds: interphase, mitotic, control cells for
stabilising and destabilising treatments, stabilising and destabilising treat-
ments in vitro, respectively.]
Fig. 6 Sensitivity analyses showing the eﬀects of small changes in the
initial model parameters on the overall outcome of the model simulations.
The histograms show the summarised scaled sensitivities of the modelled
system (y-axes) to changes in each of the initial reactant concentrations or
kinetic reaction rates (x-axes) in (A) the beta synthesis pathway and (B) the
MT dynamic instability cycle. The dark coloured bars represent initial
concentrations of the reactants; the pale coloured represent kinetic rates
(k-rates). The results show that the initial concentration of histones (HST)
and the forward rate of beta synthesis (k3f) have the greatest influences on
beta synthesis; whereas the initial concentration of MTs and the rate of
phosphorylation of free tuGDP (k6) have the greatest influences on MT
dynamic instability. (C) Representative simulations of MTs undergoing
valerate treatment showing the eﬀects of 10% changes in the HST and
k3f: (left) no change in either parameter; (centre) a 10% changes in the
initial histone concentration (HST) leads to complete loss of MT dynamicity;
(right) a 10% change in the forward rate of beta synthesis (k3f) leads to
overstabilisation of MT fibres. The eﬀects of small changes in k6 are not
shown due to the inherent instability of the oscillatory system not directly
linked to SCFA input. There is no perturbation in untreated systems. The
simulation times are 500–600 s.
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towards those associated with MT depolymerisation, and that
this was concurrent with impairment of MT structural integrity.
To test the plausibility and potential implications of this
hypothesis, we constructed a speculative model to explore the
possible impact SCFAs might have on MT dynamic instability
in colon cancer cells. The initial results showed that simula-
tions of MT dynamic instability in untreated and butyrate
treated cells in silico resembled MT behaviour observed in
interphase or untreated control cells in vitro;17 whereas simula-
tions of propionate and valerate treatments (odd-chain SCFAs)
showed close similarities to MTs under destabilising treatments
in vitro.18 The perturbation target for SCFA input in the model was
set at the dissociation step of MT dynamic instability; therefore,
increased levels of catastrophe relative to rescue had been
anticipated. However, the key finding of this study was that
the simulated outcomes were closer to those reported for
MT-destabilising treatments in vitro than mitotic cells, despite
both being associated with high levels of MT dynamicity. This
demonstrated that propionate and valerate may possess anti-
mitotic functions and suggested a potential role for odd-chain
SCFAs as anti-mitotic agents, enabling AMDs to be administered
at sub-optimal doses while maintaining eﬃcacy and inhibiting
resistance.
5. Conclusions
In combination with earlier experimental results,25 the model
presented here supports the hypothesis that propionate and
valerate at supraphysiological concentrations trigger an anti-
mitotic pathway in colon cancer cells that is unique to odd-
chain SCFAs: the simulations provoked changes inMT dynamicity
parameters that closely paralleled trends reported in cells
undergoing MT-destabilising treatments.18 This study has
demonstrated that computational dynamic modelling can
make a valuable contribution to such investigations, including
the role of SCFAs in the treatment of CRC.
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